BIMP065112

50S ribosomal protein L4

rplD

Escherichia coli K-12

Inhibitor

https://www.drugbank.ca/bio_entities/BE0003674

BIMP078763

6-phospho-beta-galactosidase

Lactococcus lactis subsp. lactis

https://www.drugbank.ca/bio_entities/BE0001435

BIMP074370

6-phospho-beta-glucosidase BglT

Thermotoga maritima MSB8

https://www.drugbank.ca/bio_entities/BE0001390

BIMP074320

6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1

PFKFB1

Homo sapiens (human)

https://www.drugbank.ca/bio_entities/BE0001073

BIMP026425

6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1

PFKFB1

Homo sapiens (human)

https://www.drugbank.ca/bio_entities/BE0001073

BIMP095003

6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1

PFKFB1

Homo sapiens (human)

https://www.drugbank.ca/bio_entities/BE0001073

BIMP095003

6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4

PFKFB4

Homo sapiens (human)

https://www.drugbank.ca/bio_entities/BE0003931

BIMP016961

6-phosphofructokinase type C

PFKP

Homo sapiens (human)

2-hexanone and 2,5-hexanedione may inhibit sulfhydryl-dependent enzymes such as fructose-6-phosphate kinase, impairing energy metabolism and subsequently resulting in axon deterioration. (A124)

http://www.t3db.ca/biodb/bio_entities/BE0005180

BIMP016961

6-phosphofructokinase, liver type

PFKL

Homo sapiens (human)

2-hexanone and 2,5-hexanedione may inhibit sulfhydryl-dependent enzymes such as fructose-6-phosphate kinase, impairing energy metabolism and subsequently resulting in axon deterioration. (A124)

http://www.t3db.ca/biodb/bio_entities/BE0005179

BIMP016961

6-phosphofructokinase, muscle type

PFKM

Homo sapiens (human)

2-hexanone and 2,5-hexanedione may inhibit sulfhydryl-dependent enzymes such as fructose-6-phosphate kinase, impairing energy metabolism and subsequently resulting in axon deterioration. (A124)

http://www.t3db.ca/biodb/bio_entities/BE0005178

BIMP103326

6-phosphogluconate dehydrogenase, decarboxylating

PGD

Homo sapiens (human)

https://www.drugbank.ca/bio_entities/BE0003559

BIMP074420

60S ribosomal protein L10-like

RPL10L

Homo sapiens (human)

https://www.drugbank.ca/bio_entities/BE0003823

BIMP074420

60S ribosomal protein L11

RPL11

Homo sapiens (human)

https://www.drugbank.ca/bio_entities/BE0003834

BIMP074420

60S ribosomal protein L13a

RPL13A

Homo sapiens (human)

https://www.drugbank.ca/bio_entities/BE0003824

BIMP074420

60S ribosomal protein L15

RPL15

Homo sapiens (human)

https://www.drugbank.ca/bio_entities/BE0003826

BIMP074420

60S ribosomal protein L19

RPL19

Homo sapiens (human)

https://www.drugbank.ca/bio_entities/BE0003827

BIMP074420

60S ribosomal protein L23

RPL23

Homo sapiens (human)

https://www.drugbank.ca/bio_entities/BE0003825

BIMP074420

60S ribosomal protein L23a

RPL23A

Homo sapiens (human)

https://www.drugbank.ca/bio_entities/BE0003828

BIMP074420

60S ribosomal protein L26-like 1

RPL26L1

Homo sapiens (human)

https://www.drugbank.ca/bio_entities/BE0003830

BIMP074420

60S ribosomal protein L3

RPL3

Homo sapiens (human)

https://www.drugbank.ca/bio_entities/BE0003833

BIMP071352

60S ribosomal protein L3

RPL3

Homo sapiens (human)

Antagonist

https://www.drugbank.ca/bio_entities/BE0003833

BIMP074420

60S ribosomal protein L37

RPL37

Homo sapiens (human)

https://www.drugbank.ca/bio_entities/BE0003832

BIMP074420

60S ribosomal protein L8

RPL8

Homo sapiens (human)

https://www.drugbank.ca/bio_entities/BE0003831

BIMP071708

6430548M08RIKL

6430548M08Rikl

Rattus norvegicus (Norway rat)

Dibutyl phthalate results in decreased expression of 6430548M08RIKL mRNA

https://ctdbase.org/detail.go?type=gene&acc=307907

BIMP072777

6430548M08RIKL

6430548M08Rikl

Rattus norvegicus (Norway rat)

Gentamicins results in increased expression of 6430548M08RIKL mRNA

https://ctdbase.org/detail.go?type=gene&acc=307907